Jodie Fernandes is the founder and CEO of JF Pharma Consulting Ltd, a leading pharmaceutical company specializing in Cholinesterase inhibitors for neurological conditions, including Alzheimer’s disease, Parkinson’s dementia, and Lewy body dementia. With over 15 years of experience in the pharmaceutical sector, Jodie combines scientific expertise with strategic leadership, guiding the company’s vision and innovation.
Her career began as a Senior Microbiologist and Senior Chemist at PQAS, where she developed a strong foundation in laboratory practices and regulatory compliance. She later served as Head of Quality at Auden McKenzie Group, overseeing pharmaceutical quality standards and ensuring product safety. In 2010, Jodie founded JF Pharma Consulting to bring cutting-edge neurological treatments to market. Under her leadership, the company has grown into a trusted and innovative partner in drug development, known for its rigorous scientific approach and commitment to patient care.